Monoclonal Gammopathy of Undetermined Significance: Predictors of Malignant Transformation and Recognition of an Evolving Type Characterized by a Progressive Increase in M Protein Size
- 30 April 2007
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 82 (4), 428-434
- https://doi.org/10.4065/82.4.428
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prevalence of Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2006
- Comparative genomic hybridisation identifies two variants of smoldering multiple myelomaBritish Journal of Haematology, 2005
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005
- Long-term Follow-up of 241 Patients With Monoclonal Gammopathy of Undetermined Significance: The Original Mayo Clinic Series 25 Years LaterMayo Clinic Proceedings, 2004
- Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002
- Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significanceBritish Journal of Haematology, 1992
- Smoldering Multiple MyelomaNew England Journal of Medicine, 1980
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence DataBiometrics, 1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958